Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schellekens

Showing results (71-80 of 155) with videos related to

Pageof 16
Sort By:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1989
Protection of rats against pseudorabies virus infection by gamma-interferonV E Schijns, B L Haagmans, H Schellekens, et al.
Clinical Pharmacology and Therapeutics|October 22, 2010
Conditional approval and approval under exceptional circumstances as regulatory instruments for stimulating responsible drug innovation in EuropeW P C Boon, E H M Moors, A Meijer, et al.
Cancer Research|April 1, 1978
Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitroE van 't Hull, H Schellekens, B Löwenberg, et al.
Virology|June 1, 1985
Human interferon does not protect cowpea plant cell protoplasts against infection with alfalfa mosaic virusM J Huisman, H J Broxterman, H Schellekens, et al.
Journal of Virological Methods|September 1, 1983
Chemical inactivation of hepatitis B virus: the effect of disinfectants on virus-associated DNA polymerase activity, morphology and infectivityC R Howard, J Dixon, P Young, et al.
Vaccine|June 1, 1990
Protective efficacy of a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine)Y Fujisawa, S Kuroda, P M Van Eerd, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 18, 2001
Oromucosal interferon therapy: relationship between antiviral activity and viral loadH Schellekens, G Geelen, J F Meritet, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1985
Infectious hepatitis B virus from cloned DNA of known nucleotide sequenceH Will, R Cattaneo, G Darai, et al.
Antiviral Research|September 1, 1981
In vivo immune stimulation by interferon during viral infectionH Schellekens, W Weimar, A De Reus, et al.
Postgraduate Medical Journal|January 1, 1987
The protection of chimpanzees against hepatitis B viral infection using a recombinant yeast-derived hepatitis B surface antigenH Schellekens, A de Reus, J H Peetermans, et al.
Pageof 16

Showing results (71-80 of 155) with videos related to

Sort By:
Pageof 16
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1989
Protection of rats against pseudorabies virus infection by gamma-interferonV E Schijns, B L Haagmans, H Schellekens, et al.
Clinical Pharmacology and Therapeutics|October 22, 2010
Conditional approval and approval under exceptional circumstances as regulatory instruments for stimulating responsible drug innovation in EuropeW P C Boon, E H M Moors, A Meijer, et al.
Cancer Research|April 1, 1978
Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitroE van 't Hull, H Schellekens, B Löwenberg, et al.
Virology|June 1, 1985
Human interferon does not protect cowpea plant cell protoplasts against infection with alfalfa mosaic virusM J Huisman, H J Broxterman, H Schellekens, et al.
Journal of Virological Methods|September 1, 1983
Chemical inactivation of hepatitis B virus: the effect of disinfectants on virus-associated DNA polymerase activity, morphology and infectivityC R Howard, J Dixon, P Young, et al.
Vaccine|June 1, 1990
Protective efficacy of a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine)Y Fujisawa, S Kuroda, P M Van Eerd, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 18, 2001
Oromucosal interferon therapy: relationship between antiviral activity and viral loadH Schellekens, G Geelen, J F Meritet, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1985
Infectious hepatitis B virus from cloned DNA of known nucleotide sequenceH Will, R Cattaneo, G Darai, et al.
Antiviral Research|September 1, 1981
In vivo immune stimulation by interferon during viral infectionH Schellekens, W Weimar, A De Reus, et al.
Postgraduate Medical Journal|January 1, 1987
The protection of chimpanzees against hepatitis B viral infection using a recombinant yeast-derived hepatitis B surface antigenH Schellekens, A de Reus, J H Peetermans, et al.
Pageof 16